Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Brade

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 11, 1997
[Mycobacterium marinum as the rare cause of a chronic skin and soft-tissue infection]K P Hunfeld, R Enzensberger, V Brade
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureusT Wichelhaus, V Schäfer, V Brade, et al.
Behring Institute Mitteilungen|February 1, 1991
Evasion of Yersinia enterocolitica serotype 03 from complement-mediated killingD Pilz, E Wachter, J Heesemann, et al.
Immunology|February 1, 1976
Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two speciesV Brade, L Dieminger, G Schmidt, et al.
Infection|July 8, 2000
Lyme arthritis in a 12-year-old patient after a latency period of 5 yearsS Albert, J Schulze, H Riegel, et al.
The Journal of Experimental Medicine|September 1, 1977
Biosynthesis of pro-C3, a precursor of the third component of complementV Brade, R E Hall, H R Colten
The Journal of Clinical Investigation|August 1, 1978
Requirements for the solubilization of immune aggregates by complement. The role of the classical pathwayM Takahashi, S Takahashi, V Brade, et al.
Deutsche Medizinische Wochenschrift (1946)|January 5, 1995
[Postmortem diagnosis of tropical malaria]S Albert, A Schröter, H Bratzke, et al.
Infection and Immunity|January 1, 1992
Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3D Pilz, T Vocke, J Heesemann, et al.
Infection|July 1, 1991
Facial palsy with elevated protein in otherwise normal CSF in a child with Lyme diseaseU Heininger, M Ries, D Harms, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Deutsche Medizinische Wochenschrift (1946)|July 11, 1997
[Mycobacterium marinum as the rare cause of a chronic skin and soft-tissue infection]K P Hunfeld, R Enzensberger, V Brade
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureusT Wichelhaus, V Schäfer, V Brade, et al.
Behring Institute Mitteilungen|February 1, 1991
Evasion of Yersinia enterocolitica serotype 03 from complement-mediated killingD Pilz, E Wachter, J Heesemann, et al.
Immunology|February 1, 1976
Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two speciesV Brade, L Dieminger, G Schmidt, et al.
Infection|July 8, 2000
Lyme arthritis in a 12-year-old patient after a latency period of 5 yearsS Albert, J Schulze, H Riegel, et al.
The Journal of Experimental Medicine|September 1, 1977
Biosynthesis of pro-C3, a precursor of the third component of complementV Brade, R E Hall, H R Colten
The Journal of Clinical Investigation|August 1, 1978
Requirements for the solubilization of immune aggregates by complement. The role of the classical pathwayM Takahashi, S Takahashi, V Brade, et al.
Deutsche Medizinische Wochenschrift (1946)|January 5, 1995
[Postmortem diagnosis of tropical malaria]S Albert, A Schröter, H Bratzke, et al.
Infection and Immunity|January 1, 1992
Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3D Pilz, T Vocke, J Heesemann, et al.
Infection|July 1, 1991
Facial palsy with elevated protein in otherwise normal CSF in a child with Lyme diseaseU Heininger, M Ries, D Harms, et al.
Pageof 11